Protocol No.: VRDN-003-302

A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with chronic thyroid eye disease (TED) REVEAL 2
Principal Investigator
Nguyen, John
Phase
III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Eye Institute
West Virginia University
Contacts